DeepMed Research

UKC Ljubljana

🇸🇮Slovenia

Country: 🇸🇮Slovenia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal

Completed

Conditions: Multiple Trauma
Shock
Atrial Fibrillation
Perioperative/Postoperative Complications

Interventions: Device: Wireless invasive blood pressure monitoring (Hybymed® Wireless IBPM System)

First Posted Date: 2011-06-15

Last Posted Date: 2011-06-15

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 12

Registration Number: NCT01373996

Regional Citrate Anticoagulation in Plasma Exchange Treatment

Not Applicable

Completed

Conditions: Focal Segmental Glomerulosclerosis
Guillain-Barre Syndrome

Interventions: Procedure: plasma exchange treatment

First Posted Date: 2011-06-09

Last Posted Date: 2015-05-27

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 140

Registration Number: NCT01370200

Locations: 🇸🇮
Center for acute and complicated dialysis, Clinical department of nephrology, UMC Ljubljana, Ljubljana, Slovenia

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

Phase 1

Completed

Conditions: Stress Urinary Incontinence

First Posted Date: 2011-05-17

Last Posted Date: 2011-05-17

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 40

Registration Number: NCT01355133

Locations: 🇸🇮
University Medical Center Ljubljana, Dept. of Gynecology, Ljubljana, Slovenia

Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy

Phase 2

Completed

Conditions: Chronic Heart Failure
Dilated Cardiomyopathy

Interventions: Procedure: Intramyocardial injection
Procedure: Intracoronary injection

First Posted Date: 2011-05-09

Last Posted Date: 2015-04-07

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 110

Registration Number: NCT01350310

Locations: 🇸🇮
UMC Ljubljana, Ljubljana, Slovenia

Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood Flow

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Procedure: Delay procedure of SIEA flap.

First Posted Date: 2010-11-24

Last Posted Date: 2010-11-24

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 26

Registration Number: NCT01247129

Locations: 🇸🇮
University Medical Centre Maribor, Maribor, Slovenia

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

Phase 4

Completed

Conditions: Superficial Thrombophlebitis

Interventions: Drug: Dalteparin

First Posted Date: 2010-11-23

Last Posted Date: 2018-05-04

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 68

Registration Number: NCT01245998

Locations: 🇸🇮
University Medical Centre Ljubljana, Ljubljana, Slovenia

Mixed Strain H. Pylori Infection in Patients Who Have Problems With Eradication of H. Pylori

Completed

Conditions: H. Pylori Eradication Failure

Interventions: Drug: Antibiotics to which H. pylori can not develope resistance

First Posted Date: 2010-07-19

Last Posted Date: 2010-07-19

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 10

Registration Number: NCT01164969

Locations: 🇸🇮
Institute of microbiology and immunology, Ljubljana, Slovenia

Antibiotic Treatment of Multiple Erythema Migrans

Not Applicable

Conditions: Multiple Erythema Migrans

Interventions: Drug: ceftriaxone
Other: erythema migrans patients treated with doxycycline
Drug: doxycycline

First Posted Date: 2010-07-16

Last Posted Date: 2017-05-05

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 500

Registration Number: NCT01163994

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

The Role of Cathepsin X in Infection With the Helicobacter Pylori

Conditions: Persistence of Infection With Helicobacter Pylori

Interventions: Drug: clarithromycin, metronidazole, proton pump inhibitor

First Posted Date: 2010-06-07

Last Posted Date: 2010-07-12

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 14

Registration Number: NCT01137942

Locations: 🇸🇮
Abakus Medico, Rogaska Slatina, Slovenia

Niacin/Laropiprant and Endothelial Function

Phase 4

Completed

Conditions: Coronary Heart Disease

Interventions: Drug: Placebo
Drug: Niacin/laropiprant

First Posted Date: 2010-05-19

Last Posted Date: 2011-10-06

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 60

Registration Number: NCT01126073

Locations: 🇸🇮
UMC Ljubljana, Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy